Breaking News

INCOG BioPharma Boosts Filling Capacity with New OPTIMA Line

Will complement the company's existing multi-use filling line, bringing the company's total filling capacity to 140 million units per year.

Author Image

By: Charlie Sternberg

Associate Editor

INCOG BioPharma Services, a US-based contract development and manufacturing organization (CDMO) specializing in sterile injectables, is adding a high-speed OPTIMA filling line that will provide an additional 100 million units of syringe and cartridge filling capacity.   This second filling line will be delivered on site this summer and qualified for GMP production in Q2 of 2025. It will complement the company’s existing multi-use filling line, bringing the company’s total filling c...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters